BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814
23 results:

  • 1. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan.
    Kito S; Suda Y; Tanabe S; Takizawa T; Nagahata T; Tohyama N; Okamoto H; Kodama T; Fujita Y; Miyashita H; Shinoda K; Kurooka M; Shimizu H; Ohno T; Sakamoto M
    J Radiat Res; 2024 Mar; 65(2):159-167. PubMed ID: 38151953
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genitourinary cancers updates: highlights from ASCO 2023.
    Qin Q; Sheffield H; Taasan SM; Wang AZ; Zhang T
    J Hematol Oncol; 2023 Nov; 16(1):112. PubMed ID: 37990343
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Precision oncology options in urological cancers].
    Franz A; Plage H; Fendler A; Schlomm T; Kornienko K
    Urologie; 2023 Jul; 62(7):696-704. PubMed ID: 37294331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
    Shirvaliloo M
    Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.
    Jiménez-Vacas JM; Montero-Hidalgo AJ; Gómez-Gómez E; Sáez-Martínez P; Fuentes-Fayos AC; Closa A; González-Serrano T; Martínez-López A; Sánchez-Sánchez R; López-Casas PP; Sarmento-Cabral A; Olmos D; Eyras E; Castaño JP; Gahete MD; Luque RM
    Transl Res; 2023 Mar; 253():68-79. PubMed ID: 36089245
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.
    Pak S; Jung KW; Park EH; Ko YH; Won YJ; Joung JY
    Investig Clin Urol; 2022 Mar; 63(2):175-183. PubMed ID: 35244991
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant prostate cancer: The CABADOC Trial.
    Baciarello G; Delva R; Gravis G; Tazi Y; Beuzeboc P; Gross-Goupil M; Bompas E; Joly F; Greilsamer C; Hon TNT; Barthelemy P; Culine S; Berdah JF; Deblock M; Ratta R; Flechon A; Cheneau C; Maillard A; Martineau G; Borget I; Fizazi K;
    Eur Urol; 2022 Mar; 81(3):234-240. PubMed ID: 34789394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deep Membrane Proteome Profiling Reveals Overexpression of prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity.
    Vit O; Patel M; Musil Z; Hartmann I; Frysak Z; Miettinen M; Pacak K; Petrak J
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770976
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
    Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
    Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hypoxia-Inducible Factor 2a Expression Is Positively Correlated With Gleason Score in prostate cancer.
    Pavlakis D; Kampantais S; Gkagkalidis K; Gourvas V; Memmos D; Tsionga A; Dimitriadis G; Vakalopoulos I
    Technol Cancer Res Treat; 2021; 20():1533033821990010. PubMed ID: 33752529
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Population-Based prostate cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study.
    Eldred-Evans D; Burak P; Connor MJ; Day E; Evans M; Fiorentino F; Gammon M; Hosking-Jervis F; Klimowska-Nassar N; McGuire W; Padhani AR; Prevost AT; Price D; Sokhi H; Tam H; Winkler M; Ahmed HU
    JAMA Oncol; 2021 Mar; 7(3):395-402. PubMed ID: 33570542
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study.
    Okura Y; Takayama T; Ozaki K; Tanaka H; Kikuchi A; Saito T; Tanigawa T; Takii Y; Seki H; Takenouchi T; Chou T; Sato N; Tanabe N; Minamino T
    Int J Clin Oncol; 2019 Aug; 24(8):983-994. PubMed ID: 30903421
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.
    Salo-Mullen EE; Lynn PB; Wang L; Walsh M; Gopalan A; Shia J; Tran C; Man FY; McBride S; Schattner M; Zhang L; Weiser MR; Stadler ZK
    Fam Cancer; 2018 Jan; 17(1):71-77. PubMed ID: 28555354
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.
    Rychtarcikova Z; Lettlova S; Tomkova V; Korenkova V; Langerova L; Simonova E; Zjablovskaja P; Alberich-Jorda M; Neuzil J; Truksa J
    Oncotarget; 2017 Jan; 8(4):6376-6398. PubMed ID: 28031527
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Incidence and Mortality of Testicular cancer and Relationships with Development in Asia.
    Sadeghi M; Ghoncheh M; Mohammadian-Hafshejani A; Gandomani HS; Rafiemanesh H; Salehiniya H
    Asian Pac J Cancer Prev; 2016; 17(9):4251-4257. PubMed ID: 27797227
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.
    Lefort K; Ostano P; Mello-Grand M; Calpini V; Scatolini M; Farsetti A; Dotto GP; Chiorino G
    Oncotarget; 2016 Jul; 7(30):48011-48026. PubMed ID: 27384993
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical prostatectomy.
    Kang M; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
    Ann Surg Oncol; 2016 Aug; 23(8):2699-706. PubMed ID: 26965702
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.
    Rand KA; Rohland N; Tandon A; Stram A; Sheng X; Do R; Pasaniuc B; Allen A; Quinque D; Mallick S; Le Marchand L; Kaggwa S; Lubwama A; ; ; Stram DO; Watya S; Henderson BE; Conti DV; Reich D; Haiman CA
    Hum Mol Genet; 2016 Jan; 25(2):371-81. PubMed ID: 26604137
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.
    Ciampa J; Yeager M; Amundadottir L; Jacobs K; Kraft P; Chung C; Wacholder S; Yu K; Wheeler W; Thun MJ; Divers WR; Gapstur S; Albanes D; Virtamo J; Weinstein S; Giovannucci E; Willett WC; Cancel-Tassin G; Cussenot O; Valeri A; Hunter D; Hoover R; Thomas G; Chanock S; Chatterjee N
    Cancer Res; 2011 May; 71(9):3287-95. PubMed ID: 21372204
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides.
    Duffield AS; Epstein JI
    Am J Surg Pathol; 2009 Jan; 33(1):120-5. PubMed ID: 18971774
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.